Flawed ivermectin preprint highlights challenges of COVID drug studies
Author:
- Sara ReardonSRSara Reardon
- 2 August 2021
- journal article
- news
- Published by Springer Nature in Nature
- Vol. 596 (7871) , 173-174
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Ivermectin for preventing and treating COVID-19Cochrane Database of Systematic Reviews, 2021
- Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical GuidelinesAmerican Journal of Therapeutics, 2021
- WITHDRAWN: Efficacy and Safety of Ivermectin for Treatment and prophylaxis of COVID-19 PandemicResearch Square, 2020
- The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitroAntiviral Research, 2020